Generex Biotech Balance Sheet - Quarterly (OTCMKTS:GNBT)

Add to My Stocks
$1.97 $0.06 (3.14%) GNBT stock closing price Sep 18, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Generex Biotech stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Generex Biotech stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Apart from analyzing Generex Biotech revenue Generex Biotech operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Generex Biotech balance sheet for 2018 Q3 shows cash on hand of $1.56M. The company has a debt to equity ratio of -.

View and download Generex Biotech quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Aug - Jul2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Marketable Securities----4M-----
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets2.76M3.26M3.01M4.24M7.16M-----
Total Assets
Notes Payable---------4.71M
Accounts Payable10.84M10.38M10.49M10.17M9.86M9.69M9.15M8.95M8.73M8.53M
Current Portion Long-Term Debt13.88M13.86M13.9M13.73M13.54M14.04M----
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities41.22M46.3M36.53M66.06M56.66M2.56M1.46M2.24M1.44M2.6M
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net2.17M----1.09M----
Capital Surplus368.4M368.4M368.4M368.4M368.4M364.06M362.78M362.78M362.77M362.78M
Retained Earnings-424.27M-427.81M-418.07M-445.72M-432.99M-390.9M-375.14M-375.7M-373.34M-374.25M
Treasury Stock----------
Other Liabilities-4.82M-2.65M-2.67M-2.56M-2.87M2.07M----
Shareholders Equity-58.52M-62.05M-52.33M-79.87M-67.46M-23.65M-10.64M-11.21M-8.87M-9.8M
Total Liabilities & Shareholders Equity7.75M8.81M8.59M10.09M13.19M2.7M--1.29M1.34M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Generex Biotech stock price, and Generex Biotech historical stock prices show the stock price movement over time, and the Generex Biotech PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: Anything that the Generex Biotech company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Generex Biotech had total assets of $7.75M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Generex Biotech's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for GNBT stock stand at $66.28M.

Generex Biotech Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover